Sapylin (OK-432) alters inflammation and angiogenesis in vivo and vitro

Volume: 113, Pages: 108706 - 108706
Published: May 1, 2019
Abstract
The occurrence of seroma formation and long-term wound healing remain challenging complications after modified radical mastectomy. Sapylin is a drug used to reduce seroma formation and enhance wound closure, but these results remain controversial. We aimed to investigate the potential mechanism. A prospective, consecutive cohort study included 120 patients diagnosed with breast cancer who underwent modified radical mastectomy was designed....
Paper Details
Title
Sapylin (OK-432) alters inflammation and angiogenesis in vivo and vitro
Published Date
May 1, 2019
Volume
113
Pages
108706 - 108706
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.